Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pirkko T Vihko

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 18, 2013
Structure of Acid phosphatasesCésar L Araujo, Pirkko T Vihko
Methods in Molecular Biology (Clifton, N.J.)|July 18, 2013
Purification of prostatic acid phosphatase (PAP) for structural and functional studiesAnnakaisa M Herrala, Ileana B Quintero, Pirkko T Vihko
International Journal of Cancer|January 5, 2002
Downregulation of estrogen-metabolizing 17 beta-hydroxysteroid dehydrogenase type 2 expression correlates inversely with Ki67 proliferation marker in colon-cancer developmentOlayiwola O Oduwole, Veli V Isomaa, Pasi A Nokelainen, et al.
Anticancer Research|December 12, 2003
Sex steroid metabolism in human gastric mucosa: 17 beta-hydroxysteroid dehydrogenase type 2 in normal, inflamed and neoplastic gastric tissuesOlayiwola O Oduwole, Johanna M Mäkinen, Veli V Isomaa, et al.
The Prostate|October 1, 2015
Transmembrane prostatic acid phosphatase (TMPAP) delays cells in G1 phase of the cell cycleCésar L Araujo, Ileana B Quintero, Kristian Ovaska, et al.
Cancer Research|October 20, 2004
17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancerOlayiwola O Oduwole, Yan Li, Veli V Isomaa, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 16, 2003
17Beta-hydroxysteroid dehydrogenase type 2: independent prognostic significance and evidence of estrogen protection in female patients with colon cancerOlayiwola O Oduwole, Markus J Mäkinen, Veli V Isomaa, et al.
Cancer Research|July 20, 2007
Prostatic acid phosphatase is not a prostate specific targetIleana B Quintero, César L Araujo, Anitta E Pulkka, et al.
Plos One|September 17, 2013
Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate adenocarcinomaIleana B Quintero, Annakaisa M Herrala, César L Araujo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|July 18, 2013
Structure of Acid phosphatasesCésar L Araujo, Pirkko T Vihko
Methods in Molecular Biology (Clifton, N.J.)|July 18, 2013
Purification of prostatic acid phosphatase (PAP) for structural and functional studiesAnnakaisa M Herrala, Ileana B Quintero, Pirkko T Vihko
International Journal of Cancer|January 5, 2002
Downregulation of estrogen-metabolizing 17 beta-hydroxysteroid dehydrogenase type 2 expression correlates inversely with Ki67 proliferation marker in colon-cancer developmentOlayiwola O Oduwole, Veli V Isomaa, Pasi A Nokelainen, et al.
Anticancer Research|December 12, 2003
Sex steroid metabolism in human gastric mucosa: 17 beta-hydroxysteroid dehydrogenase type 2 in normal, inflamed and neoplastic gastric tissuesOlayiwola O Oduwole, Johanna M Mäkinen, Veli V Isomaa, et al.
The Prostate|October 1, 2015
Transmembrane prostatic acid phosphatase (TMPAP) delays cells in G1 phase of the cell cycleCésar L Araujo, Ileana B Quintero, Kristian Ovaska, et al.
Cancer Research|October 20, 2004
17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancerOlayiwola O Oduwole, Yan Li, Veli V Isomaa, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 16, 2003
17Beta-hydroxysteroid dehydrogenase type 2: independent prognostic significance and evidence of estrogen protection in female patients with colon cancerOlayiwola O Oduwole, Markus J Mäkinen, Veli V Isomaa, et al.
Cancer Research|July 20, 2007
Prostatic acid phosphatase is not a prostate specific targetIleana B Quintero, César L Araujo, Anitta E Pulkka, et al.
Plos One|September 17, 2013
Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate adenocarcinomaIleana B Quintero, Annakaisa M Herrala, César L Araujo, et al.
Pageof 1